XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Numerator:        
Net income (loss) $ 3,729 $ (26,429) $ 10,028 $ (97,007)
Less: Net income (loss) attributable to noncontrolling interests 0 (16) (254) (63)
Net income (loss) attributable to Alignment Healthcare, Inc. $ 3,729 $ (26,413) $ 10,282 $ (96,944)
Denominator:        
Total weighted-average common shares outstanding (in shares) 199,026,808 191,610,696 197,022,500 190,882,849
Less: Restricted shares of common stock (in shares) 0 (249,413) (15,359) (459,835)
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares) 199,026,808 191,361,283 197,007,141 190,423,014
Dilutive effect of:        
Shares used to compute diluted income (loss) per common share (in shares) 208,927,980 191,361,283 208,439,200 190,423,014
Net income (loss) per share:        
Basic income (loss) per share (in dollars per share) $ 0.02 $ (0.14) $ 0.05 $ (0.51)
Diluted income (loss) per share (in dollars per share) $ 0.02 $ (0.14) $ 0.05 $ (0.51)
Stock options        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 309,030 0 354,209 0
RSUs        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 7,297,588 0 8,057,026 0
PSUs        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 2,294,554 0 3,020,824 0